Goldman Sachs Put 500 VRTX 18.10..../ DE000GJ0CMX5 /
| 7/30/2024 10:42:29 AM | Chg.-0.23 | Bid8:01:05 PM | Ask8:01:05 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 1.94EUR | -10.60% | 2.03 Bid Size: 3,000 |
2.13 Ask Size: 3,000 |
Vertex Pharmaceutica... | 500.00 USD | 10/18/2024 | Put |
GlobeNewswire
6/28
Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...
GlobeNewswire
6/10
Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...
GlobeNewswire
5/15
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/9
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire
5/8
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
5/8
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo ...
GlobeNewswire
5/7
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
4/30
American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Dis...
GlobeNewswire
4/27
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN
GlobeNewswire
4/22
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire
4/22
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASG...
GlobeNewswire
4/9
American Kidney Fund and Alonzo Mourning Call for More Awareness and Understanding of APOL1-Mediated...
